Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients

Chronic hepatitis B (CHB) infection functional cure is defined as sustained loss of HBsAg and several therapeutic strategies are in clinical development designed to pharmacologically reduce serum HBsAg, break immune tolerance, and increase functional cure rates. However, little is known about pre-tr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Kim, Jin Hyang, Ghosh, Alip, Ayithan, Natarajan, Romani, Sara, Khanam, Arshi, Park, Jang-June, Rijnbrand, Rene, Tang, Lydia, Sofia, Michael J., Kottilil, Shyam, Moore, Chris B., Poonia, Bhawna
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7000714/
https://ncbi.nlm.nih.gov/pubmed/32020034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-58870-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars